NV

Neelam Vyas

Active Director Director DIN 02435581
DIN 02435581 First appointment Dec 2006 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Dec 2006
Shareholding value •••• Premium profile

About Neelam Vyas

Data last updated:

Neelam Vyas is a Director at Mednext Biotech Limited (since 2012), Director at Alice Pharma Private Limited (since 2006) and Director at Tirtham Hospitality Private Limited (since 2021), and holds 2 more current directorships. The companies operate in Pharma and Financial Services. The 5 current companies with reported revenue have a combined latest revenue of ₹64.78 Cr; the largest is Mednext Biotech Limited at ₹36.86 Cr (FY 2025). Earlier, Neelam Vyas was a Director at Mercure Lifesciences Private Limited (from 2010).

DIN 02435581
Primary Designation Director
Industry Pharma
First Appointment 05 Dec 2006
Oldest Company Age 19 yrs
Largest company Mednext Biotech Limited · ₹36.86 Cr (FY 2025)
Combined revenue ₹64.78 Cr across 5 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mednext Biotech Limited U24232RJ2012PLC039813
Director17 Aug 20122012₹36.86 Cr (FY 2025)Active
Alice Pharma Private Limited U24232MP2006PTC019099
Director05 Dec 20062006₹21.91 Cr (FY 2025)Active
Tirtham Hospitality Private Limited U55101RJ2021PTC076956
Director13 Sep 20212021₹2.75 Cr (FY 2024)Active
Mednext Pharma Private Limited U24110MH2009PTC190076
Director04 Mar 20172009₹2.56 Cr (FY 2024)Active
Director02 Apr 20092009₹69.9 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mercure Lifesciences Private Limited U85100MH2010PTC202070
Director15 Apr 20102010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mednext Pharma Private Limited
Alice Pharma Private Limited
Mednext Biotech Limited
Alice Pharma (Mumbai) Private Limited
Premium access

Shareholding and investment profile for Neelam Vyas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neelam Vyas

Neelam Vyas currently holds 5 directorships: Mednext Biotech Limited (Director, since 17 Aug 2012, revenue ₹36.86 Cr (FY 2025)); Alice Pharma Private Limited (Director, since 05 Dec 2006, revenue ₹21.91 Cr (FY 2025)); Tirtham Hospitality Private Limited (Director, since 13 Sep 2021, revenue ₹2.75 Cr (FY 2024)); Mednext Pharma Private Limited (Director, since 04 Mar 2017, revenue ₹2.56 Cr (FY 2024)); Alice Pharma (Mumbai) Private Limited (Director, since 02 Apr 2009, revenue ₹69.9 Lakh (FY 2025)).

Neelam Vyas was first appointed on 05 Dec 2006 as Director at Alice Pharma Private Limited. The most recent appointment on record is 13 Sep 2021 at Tirtham Hospitality Private Limited.

The 5 current companies of Neelam Vyas that report revenue have a combined latest revenue of ₹64.78 Cr: Mednext Biotech Limited ₹36.86 Cr (FY 2025); Alice Pharma Private Limited ₹21.91 Cr (FY 2025); Tirtham Hospitality Private Limited ₹2.75 Cr (FY 2024); Mednext Pharma Private Limited ₹2.56 Cr (FY 2024); Alice Pharma (Mumbai) Private Limited ₹69.9 Lakh (FY 2025).

Neelam Vyas held 1 earlier board appointment: Mercure Lifesciences Private Limited (Director, from 15 Apr 2010).

The current boards of Neelam Vyas's companies include Anil Kumar Vyas (Mednext Biotech Limited), Shriansh Vyas (Mednext Biotech Limited), Alex Charles Fernandes (Alice Pharma Private Limited), Leena Alex Fernandes (Alice Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available